Violet Therapeutics
PrivateLast Round
Seed
May 13, 2026
Total Funding Raised
$15.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Violet Therapeutics operates in Healthcare & Life Sciences and is based in Somerville, Massachusetts. Its latest recorded funding round was a Seed round in May 2026.
Violet Therapeutics is a biotechnology company that develops first-in-class small molecule therapies for neurodegenerative diseases by utilizing a proprietary platform to map disease-relevant cell-to-cell signaling interactions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Violet Therapeutics Comparables
Compare Violet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muna Therapeutics | 80% | |
| Cerevance | 76% | |
| Montara Therapeutics | 71% |
For institutional investors. Book with your work email.
Violet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2026 | ||||
| Seed | May 31, 2023 |
For institutional investors. Book with your work email.
Violet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ono Venture Investment, Inc. | Seed |
| SV Health Investors | Seed |
| UTEC (The University of Tokyo Edge Capital Partners) | Seed |
| Mass General Brigham Innovation | Seed |
| Ono Venture Investment, Inc. | Seed |
| OVI Partners | Seed |
| LifeSpan Vision Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$4.75M round led by LifeSpan Vision Ventures.
- May 31, 2023
$11M round led by Mass General Brigham Innovation and SV Health Investors.
For institutional investors. Book with your work email.
Violet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Violet Therapeutics's valuation, stock price, and market status.
Is Violet Therapeutics a public or private company?
Violet Therapeutics is a private company.
What is the current stock price of Violet Therapeutics?
Violet Therapeutics is a private company, so its shares have no public market price. Caplight tracks Violet Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Violet Therapeutics worth (valuation)?
Valuation information for Violet Therapeutics is not publicly available.
Can I buy Violet Therapeutics stock?
Violet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Violet Therapeutics's last funding round?
Violet Therapeutics's most recent funding round was Seed on May 13, 2026.
Who are the main investors in Violet Therapeutics?
Key investors in Violet Therapeutics include SV Health Investors, UTEC (The University of Tokyo Edge Capital Partners), Mass General Brigham Innovation, LifeSpan Vision Ventures.
Will Violet Therapeutics IPO soon?
No public IPO plans have been announced for Violet Therapeutics.
How can I track Violet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Violet Therapeutics's shares on secondary markets.